This report describes general characteristics of several diseases classified as D-2-hydroxyglutaric aciduria (D2HGA). D2HGA is a genetically heterogeneous disorder, with at least two implicated genes. A listing of D2HGA subtypes, as defined by OMIM, may be found in the table below, with links to more detailed reports for subtypes that have been investigated using fly models. D2HGA is distinct from L-2-hydroxyglutaric aciduria (L2HGA); both are described in the Genetics Home Reference page for 2-hydroxyglutaric aciduria (see link below).
[updated Dec. 2015 by FlyBase; FBrf0222196]
D-2-hydroxyglutaric aciduria is a neurometabolic disorder. Symptoms are varible, ranging from asymptomatic to developmental delay, epilepsy, hypotonia (weak muscle tone), and dysmorphic features. Severe cases are characterized by early infantile-onset epileptic encephalopathy and, often, cardiomyopathy. [from MIM:600721, MIM:613657; 2015.12.21]
D-2-hydroxyglutaric aciduria (D2HGA) is a genetically heterogeneous disorder, with two implicated genes to date. [from MIM:600721; 2015.12.21]